Skip to content

Clinical trials

Hypercholesterolemia trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Country / region: Austria Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20123
20133
20153
20163
20172
20182
20202
20212
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Sanofi5
Novartis Pharmaceuticals4
Medical University of Graz3
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Medical University of Vienna2
Regeneron Pharmaceuticals2
Affiris AG1
Daiichi Sankyo1
Mylan Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia28
Cardiovascular Diseases6
Dyslipidemias6
Hyperlipidemias5
Atherosclerosis4
Hyperlipoproteinemia Type II3
Aortic Valve Stenosis2
Heart Failure2
Homozygous Familial Hypercholesterolemia2
Cholestasis1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.